InvestorsHub Logo
Followers 195
Posts 24520
Boards Moderated 0
Alias Born 04/03/2010

Re: exwannabe post# 688830

Friday, 05/03/2024 2:58:52 PM

Friday, May 03, 2024 2:58:52 PM

Post# of 693785
Funny when you laugh. It usually means the opposite. NWBO is not a CDMO. I do not expect them to enter that space.

Yes, Flaskworks was picked up for a song, because at least for now, NWBO has a huge head start on this particular segment of immunotherapies.

The notion that there are others with far more advanced technology in this particular space is not true. Yes, there are CDMO companies that help other companies just like Advent and its predecessor. Of course there are. But this is the only company going commercial in this space with automation and dendritic cells are a particular, sticky animal. No one else is advanced or has debugged any technology remotely similar for automating a process as complicated as this though I am sure you’ll find some random webpage making such a claim. It’s just not true, and the only company out there has helped with this technology and is likely locked under contract.

The reality is, even those companies that claim t have automated car-t processes have not yet had their technologies fully validated or solves the problem that currently leaves those companies unable to meet demand and with extremely high costs, regardless of claims to the contrary.

But yeah, laugh all you want. It doesn’t change reality. It’s empty.

I agree it was picked up for a song.

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News